Literature DB >> 26464747

Alveolar soft part sarcoma presenting as a breast metastasis in a patient with a history of thyroid cancer: a case report.

Andrey Bychkov1, Pichet Sampatanukul1.   

Abstract

Metastases to the breast are uncommon, accounting for 0.5% of breast tumors, and most of them are originated from lymphoma, melanoma and carcinomas of various organs. Alveolar soft part sarcoma (ASPS) is a very rare neoplasm that is usually found in the lower extremities. Lungs are the common site of dissemination and may represent initial manifestation of disease. We report a clinically unsuspected case of ASPS presenting as a breast metastasis in a 25-year-old woman. The patient's medical history was notable for a thyroid cancer treated by surgery and radioiodine ablation 2 years ago. Core needle biopsy of slowly growing breast mass yielded polygonal cells with abundant eosinophilic cytoplasm arranged into solid pattern. Differential diagnosis between apocrine cell carcinoma, paraganglioma, granular cell tumor, neuroendocrine carcinoma, ASPS and metastatic hepatocellular and renal cell carcinoma was rendered by immunohistochemistry. Strong nuclear TFE3 immunoreactivity confirmed a diagnosis of ASPS. Retrospectively a primary tumor was found in the thigh. Most likely, ASPS and thyroid cancer in the patient were growing synchronously and independently.

Entities:  

Keywords:  Alveolar soft part sarcoma; biopsy; breast metastasis; thyroid cancer

Mesh:

Year:  2015        PMID: 26464747      PMCID: PMC4583979     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

1.  Bilateral mammary metastasis of alveolar soft part sarcoma--a case report.

Authors:  G A Muzumdar; A K Murthy
Journal:  Indian J Pathol Microbiol       Date:  1996-10       Impact factor: 0.740

2.  Genome-wide appraisal of thyroid cancer progression.

Authors:  Volkert B Wreesmann; Ronald A Ghossein; Snehal G Patel; Charles P Harris; Erik A Schnaser; Ashok R Shaha; R Michael Tuttle; Jatin P Shah; Pulivarthi H Rao; Bhuvanesh Singh
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Immunohistochemical profile of myogenin and MyoD1 does not support skeletal muscle lineage in alveolar soft part sarcoma.

Authors:  J A Gómez; M B Amin; J Y Ro; M D Linden; M W Lee; R J Zarbo
Journal:  Arch Pathol Lab Med       Date:  1999-06       Impact factor: 5.534

4.  A proposed explanation for female predominance in alveolar soft part sarcoma. Noninactivation of X; autosome translocation fusion gene?

Authors:  Xiangdong Bu; Leslie Bernstein
Journal:  Cancer       Date:  2005-03-15       Impact factor: 6.860

Review 5.  Alveolar soft-part sarcoma: a review and update.

Authors:  A L Folpe; A T Deyrup
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

6.  Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution.

Authors:  C A Portera ; V Ho; S R Patel; K K Hunt; B W Feig; P M Respondek; A W Yasko; R S Benjamin; R E Pollock; P W Pisters
Journal:  Cancer       Date:  2001-02-01       Impact factor: 6.860

7.  Alveolar soft part sarcoma metastatic to the breast.

Authors:  N N Hanna; K O'Donnell; G R Wolfe
Journal:  J Surg Oncol       Date:  1996-02       Impact factor: 3.454

8.  Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival.

Authors:  Stephanie A Williams; Richard A Ehlers; Kelly K Hunt; Min Yi; Henry M Kuerer; S Eva Singletary; Merrick I Ross; Barry W Feig; W Fraser Symmans; Funda Meric-Bernstam
Journal:  Cancer       Date:  2007-08-15       Impact factor: 6.860

9.  Alveolar soft part sarcoma with breast metastases: a case report.

Authors:  George Orphanos; Georgios Ioannidis; Rena Ioannou; Ioanna Zouvani
Journal:  Med Oncol       Date:  2012-12-24       Impact factor: 3.064

10.  Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.

Authors:  J P Neglia; D L Friedman; Y Yasui; A C Mertens; S Hammond; M Stovall; S S Donaldson; A T Meadows; L L Robison
Journal:  J Natl Cancer Inst       Date:  2001-04-18       Impact factor: 11.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.